Workflow
半导体概念
icon
Search documents
【环球财经】东京股市显著上涨 日经225指数创下约三个月新高
Xin Hua Cai Jing· 2025-05-29 08:25
收盘时,日经股指上涨710.58点,报38432.98点,为约三个月以来的高位,涨幅1.88%;东京证券交易 所股票价格指数上涨42.51点,收于2812.02点,涨幅1.53%。 东京证券交易所33个行业板块当天除陆地运输业、海洋运输业和纸浆及造纸3个板块微跌外,其余板块 均收涨。其中,有色金属、运输机械两大板块涨幅超过3%领涨。 (文章来源:新华财经) 受美国国际贸易法院"叫停"特朗普政府一揽子关税、美国半导体企业业绩良好、日元贬值等因素影响, 东京股市29日高开高走,日经225指数创下2025年2月25日以来的收盘新高。 美国大型半导体企业英伟达当地时间28日发布2025年2月至4月财报。由于业绩数据好于市场预期,东京 股市半导体概念股也受到投资者青睐,买盘占据主导。由于业绩数据好于市场预期,东京股市半导体概 念股也受到投资者青睐,买盘占据主导。东京股市29日较大幅度高开,日经股指开盘即站上38000点大 关。外汇市场日元出现较大幅度贬值,日元对美元一度进入146:1区间,业绩预期改善的出口相关股被 买入,带动大盘继续上行。 美国国际贸易法院28日(东京时间29日上午)裁定暂停特朗普政府4月2日宣布的一 ...
港股收盘(05.26) | 恒指收跌1.35% 科技股、汽车股下挫 核电概念逆市走强
智通财经网· 2025-05-26 08:48
Market Overview - The Hong Kong stock market opened lower, with all three major indices falling over 1%. The Hang Seng Index closed down 1.35% at 23,282.33 points, with a total turnover of HKD 223.52 billion [1] - The Hang Seng China Enterprises Index and the Hang Seng Tech Index both dropped 1.7% [1] Blue Chip Performance - Nongfu Spring (09633) led blue-chip stocks, rising 3.83% to HKD 38, contributing 4.69 points to the Hang Seng Index. Huachuang Securities upgraded the stock to "strong buy" due to its solid growth potential [2] - Other notable blue-chip movements included China Resources Power (00836) up 2.57% and Xinyi Glass (00868) up 2.42%, while Zhongsheng Holdings (00881) and BYD Electronics (00285) saw declines of 3.96% and 3.56%, respectively [2] Sector Highlights - Large tech stocks collectively declined, with Xiaomi down 3.21% and Alibaba down 1.6%. The automotive sector faced significant pressure due to a price war, leading to notable declines in automotive stocks [3][7] - Nuclear power stocks surged following President Trump's signing of executive orders to boost the U.S. nuclear industry. China National Nuclear Power (02302) rose 129.78% [3][4] - The aviation sector showed strong performance, with China National Aviation (00753) up 5.58% and Eastern Airlines (00670) up 3.69% [4] Financial Performance - The civil aviation sector reported strong growth in April, with passenger transport volume increasing by 8.9% year-on-year. Q2 profitability is expected to improve due to high passenger traffic and rising seat occupancy rates [5] - Semiconductor stocks were active, with Huahong Semiconductor (01347) up 2.6% and SMIC (00981) up 0.72% [5] Corporate News - Haiguang Information announced plans to merge with Zhongke Shuguang through a share swap, aiming to enhance its capabilities in high-end computing and core chip design [6] - ZTO Express (00780) reported a 13.2% year-on-year revenue increase in Q1, reaching CNY 4.377 billion, with adjusted EBITDA growing by 41.3% [9] - Jin Chaoyang Group (00878) faced a significant drop of 15.25% after its privatization proposal was rejected [10] - Giant Bio (02367) experienced a decline of 4.04% following negative publicity regarding its product's collagen content [11]
601939、600919,历史新高!
新华网财经· 2025-05-09 04:52
Core Viewpoint - The A-share market showed weakness with major indices declining, while dividend stocks, particularly in the banking and power sectors, performed strongly, indicating a shift towards defensive investments in uncertain market conditions [1][2][8]. Group 1: Dividend Assets Performance - Dividend assets, particularly in the banking sector, have regained attention as a stabilizing force in the market, with China Construction Bank and Jiangsu Bank reaching new historical highs [2][3]. - The performance of high-dividend stocks has been relatively stable, supported by external factors and the recent disclosure of annual and quarterly reports, which enhance the certainty of earnings in these sectors [8]. - Analysts suggest that investors should focus on high-dividend assets with strong fundamentals and lower internal crowding, especially in light of ongoing external disturbances [8]. Group 2: Innovation Drug Sector - The innovation drug sector showed initial strength, with stocks like Shuyou Shen rising over 15% at one point, reflecting positive market sentiment [9][10]. - Analysts believe that the pharmaceutical industry is poised for valuation recovery by 2025, driven by policy support, improved market recognition, and advancements in research and development [12]. - Investment opportunities are recommended in the innovation drug supply chain, high-end medical devices, and medical consumption terminals, particularly in companies with strong innovation capabilities and rich product pipelines [12]. Group 3: Semiconductor Sector - The semiconductor sector experienced significant declines, with leading companies like Huahong Semiconductor and SMIC seeing drops of 10.58% and 4.37%, respectively, negatively impacting overall market sentiment [13][15]. - Despite the traditional off-season in Q1, the semiconductor industry reported revenue and profit growth, indicating resilience due to demand for computing chips and advancements in self-sufficiency across various segments [16][17]. - Analysts maintain an overweight rating on the semiconductor sector, highlighting the clear trends of AI integration and self-sufficiency as key growth drivers [17].